{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/54.1-3456.1.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/54.1-3456.1.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/54.1-3456.1.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/54.1-3456.1.html"}],"law_id":54792,"edition_id":1,"section_id":54792,"structure_id":13782,"section_number":"54.1-3456.1","catch_line":"Drugs of concern","history":"2014, c. 664; 2017, c. 181; 2019, c. 214.","full_text":"The Board may promulgate regulations designating specific drugs and substances, including any controlled substance or other drug or substance where there has been or there is the actual or relative potential for abuse, as drugs of concern. Drugs or substances designated as drugs of concern shall be reported to the Department of Health Professions and shall be subject to reporting requirements for the Prescription Monitoring Program established pursuant to Chapter 25.2 (\u00a7 54.1-2519 et seq.).","order_by":null,"text":{"0":{"id":201079,"text":"The Board may promulgate regulations designating specific drugs and substances, including any controlled substance or other drug or substance where there has been or there is the actual or relative potential for abuse, as drugs of concern. Drugs or substances designated as drugs of concern shall be reported to the Department of Health Professions and shall be subject to reporting requirements for the Prescription Monitoring Program established pursuant to Chapter 25.2 (\u00a7 54.1-2519 et seq.).","type":"section","prefixes":[""],"prefix":"","entire_prefix":"","prefix_anchor":"","level":1}},"ancestry":[{"id":13782,"edition_id":1,"name":"Standards and Schedules","identifier":"5","label":"article","depth":4,"order_by":1,"parent_id":13240,"metadata":{},"date_created":"2026-06-26 03:45:52","date_modified":"2026-06-26 03:45:52","permalink":{"id":243623,"object_type":"structure","relational_id":13782,"identifier":"5","token":"54.1\/III\/34\/5","url":"\/54.1\/III\/34\/5\/","edition_id":1,"permalink":0,"preferred":1}},{"id":13240,"edition_id":1,"name":"Drug Control Act","identifier":"34","label":"chapter","depth":3,"order_by":1,"parent_id":12758,"metadata":{},"date_created":"2026-06-26 03:44:30","date_modified":"2026-06-26 03:44:30","permalink":{"id":243223,"object_type":"structure","relational_id":13240,"identifier":"34","token":"54.1\/III\/34","url":"\/54.1\/III\/34\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12758,"edition_id":1,"name":"Professions and Occupations Regulated by Boards Within the Department of Health Professions","identifier":"III","label":"subtitle","depth":2,"order_by":1,"parent_id":12754,"metadata":{},"date_created":"2026-06-26 03:43:51","date_modified":"2026-06-26 03:43:51","permalink":{"id":241105,"object_type":"structure","relational_id":12758,"identifier":"III","token":"54.1\/III","url":"\/54.1\/III\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12754,"edition_id":1,"name":"Professions and Occupations","identifier":"54.1","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:43:51","date_modified":"2026-06-26 03:43:51","permalink":{"id":239313,"object_type":"structure","relational_id":12754,"identifier":"54.1","token":"54.1","url":"\/54.1\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":66818,"structure_id":13782,"section_number":"54.1-3443","catch_line":"Board to administer article","url":"\/54.1-3443\/","token":"54.1\/III\/34\/5\/54.1-3443","metadata":false},{"id":70506,"structure_id":13782,"section_number":"54.1-3444","catch_line":"Controlled substances included by whatever name designated","url":"\/54.1-3444\/","token":"54.1\/III\/34\/5\/54.1-3444","metadata":false},{"id":55398,"structure_id":13782,"section_number":"54.1-3445","catch_line":"Placement of substance in Schedule I","url":"\/54.1-3445\/","token":"54.1\/III\/34\/5\/54.1-3445","metadata":false},{"id":61892,"structure_id":13782,"section_number":"54.1-3446","catch_line":"Schedule I","url":"\/54.1-3446\/","token":"54.1\/III\/34\/5\/54.1-3446","metadata":false},{"id":65202,"structure_id":13782,"section_number":"54.1-3447","catch_line":"Placement of substance in Schedule II","url":"\/54.1-3447\/","token":"54.1\/III\/34\/5\/54.1-3447","metadata":false},{"id":56998,"structure_id":13782,"section_number":"54.1-3448","catch_line":"Schedule II","url":"\/54.1-3448\/","token":"54.1\/III\/34\/5\/54.1-3448","metadata":false},{"id":62478,"structure_id":13782,"section_number":"54.1-3449","catch_line":"Placement of substance in Schedule III","url":"\/54.1-3449\/","token":"54.1\/III\/34\/5\/54.1-3449","metadata":false},{"id":76280,"structure_id":13782,"section_number":"54.1-3450","catch_line":"Schedule III","url":"\/54.1-3450\/","token":"54.1\/III\/34\/5\/54.1-3450","metadata":false},{"id":56931,"structure_id":13782,"section_number":"54.1-3451","catch_line":"Placement of substance in Schedule IV","url":"\/54.1-3451\/","token":"54.1\/III\/34\/5\/54.1-3451","metadata":false},{"id":62803,"structure_id":13782,"section_number":"54.1-3452","catch_line":"Schedule IV","url":"\/54.1-3452\/","token":"54.1\/III\/34\/5\/54.1-3452","metadata":false},{"id":67045,"structure_id":13782,"section_number":"54.1-3453","catch_line":"Placement of substance in Schedule V","url":"\/54.1-3453\/","token":"54.1\/III\/34\/5\/54.1-3453","metadata":false},{"id":86457,"structure_id":13782,"section_number":"54.1-3454","catch_line":"Schedule V","url":"\/54.1-3454\/","token":"54.1\/III\/34\/5\/54.1-3454","metadata":false},{"id":82814,"structure_id":13782,"section_number":"54.1-3455","catch_line":"Schedule VI","url":"\/54.1-3455\/","token":"54.1\/III\/34\/5\/54.1-3455","metadata":false},{"id":87313,"structure_id":13782,"section_number":"54.1-3456","catch_line":"Controlled substance analog","url":"\/54.1-3456\/","token":"54.1\/III\/34\/5\/54.1-3456","metadata":false},{"id":54792,"structure_id":13782,"section_number":"54.1-3456.1","catch_line":"Drugs of concern","url":"\/54.1-3456.1\/","token":"54.1\/III\/34\/5\/54.1-3456.1","metadata":false}],"previous_section":{"id":87313,"structure_id":13782,"section_number":"54.1-3456","catch_line":"Controlled substance analog","url":"\/54.1-3456\/","token":"54.1\/III\/34\/5\/54.1-3456","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/54.1-3456.1\/","history_text":"<p>This law was first created in 2014. The record of its establishment is cataloged in chapter <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?141+ful+CHAP0664\">664<\/a> of that year\u2019s edition of \u201cActs of Assembly,\u201d the annual state publication listing all changes made to the Code of Virginia in that year. It has been modified 2 times. Those modifications are cataloged by \u201cThe Acts of Assembly,\u201d a state publication, by year and chapter. Those modifications that can be read on the General Assembly\u2019s website will be linked accordingly. Those modifications are as follows: in 2017, chapter <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?171+ful+CHAP0181\">181<\/a>; in 2019, chapter <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?191+ful+CHAP0214\">214<\/a>.<\/p>","references":[{"id":68394,"section_number":"54.1-2519","catch_line":"Definitions","order_by":null,"url":"\/54.1-2519\/"}],"refers_to":[{"id":68394,"section_number":"54.1-2519","catch_line":"Definitions","order_by":null,"url":"\/54.1-2519\/"}],"permalink":{"id":243681,"object_type":"law","relational_id":54792,"identifier":"54.1-3456.1","token":"54.1\/III\/34\/5\/54.1-3456.1","url":"\/54.1-3456.1\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/54.1-3456.1\/","token":"54.1\/III\/34\/5\/54.1-3456.1","dublin_core":{"Title":"Drugs of concern","Type":"Text","Format":"text\/html","Identifier":"\u00a7 54.1-3456.1","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t<section><p>The <span class=\"dictionary\">Board<\/span> may promulgate regulations designating specific <span class=\"dictionary\">drugs<\/span> and substances, including any <span class=\"dictionary\">controlled substance<\/span> or other <span class=\"dictionary\">drug<\/span> or substance where there has been or there is the actual or relative potential for abuse, as <span class=\"dictionary\">drugs<\/span> of concern. <span class=\"dictionary\">Drugs<\/span> or substances designated as <span class=\"dictionary\">drugs<\/span> of concern shall be reported to the Department of Health Professions and shall be subject to reporting requirements for the <span class=\"dictionary\">Prescription<\/span> Monitoring Program established pursuant to Chapter 25.2 (\u00a7&nbsp;<a class=\"law\" title=\"Definitions\" href=\"\/54.1-2519\/\">54.1-2519<\/a> et seq.).<\/p><\/section>","plain_text":"                                 CODE OF VIRGINIA\n\nDRUGS OF CONCERN (\u00a7 54.1-3456.1)\n\nThe Board may promulgate regulations designating specific drugs and substances,\nincluding any controlled substance or other drug or substance where there has\nbeen or there is the actual or relative potential for abuse, as drugs of\nconcern. Drugs or substances designated as drugs of concern shall be reported to\nthe Department of Health Professions and shall be subject to reporting\nrequirements for the Prescription Monitoring Program established pursuant to\nChapter 25.2 (\u00a7 54.1-2519 et seq.).\n\nHISTORY: 2014, c. 664; 2017, c. 181; 2019, c. 214.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}